InvestorsHub Logo

drv17

05/09/19 8:52 AM

#192153 RE: nidan7500 #192150

Some on the board have expressed concern about the ability of Anavex to have the capability to supply A2-73
(and rightly so) if and when it is approved for multiple CNS diseases. .
I think we should propose that long term shareholders be provided with a "Priority Prescription" so that we would first in line to receive this drug. LOL !!!

jimmy667

05/09/19 12:53 PM

#192223 RE: nidan7500 #192150

Dr Missling clued you in as the number of the pills. It was stated to be enough for the entire population of Manhattan NY. 1.665 million people. So also one can see it is very cheap to manufacture at a maximum of $0.60 per pill.
These are the easy dots to follow bro.